Saturday, February 14, 2015

CAPLIN POINT LABORATORIES LTD - UPDATE




CAPLIN POINT LABORATORIES LTD is a stock recommended exactly one year back @ Rs.86. Yesterday stock hits life time high @ Rs.707 and closed in upper circuit. Stock already  turned as a multi bagger and returned a whopping 800 % in one year. Those who are not interested to take bit higher level of risk may sell part of holding  to recover your cost  plus a decent profit and HOLD the remaining as cost free. 

Recommendation Link HERE

60 comments :

  1. Sir I am holding orchid chemical and friends told me sell it on Monday as result were not good but don't know about result .and I can't sell it without you suggession please update on it so that I may aware about facts thanks

    ReplyDelete
    Replies
    1. Major reason for sizable loss of Orchid in this quarter is due to forex loss.

      Delete
  2. sir V2retail and nathbiogene both reported very good results (according to me i may be wrong) but why the market is not rewarding them i mean their price are not increasing ?

    ReplyDelete
    Replies
    1. Price movement is beyond my control. I believe ,market will give deserving valuation to any growing business sooner or later.

      Delete
  3. Sir your view on Hind Dorr Oliver and AGC Networks Ltd for long term??

    Holding godavari from 40 and will add more at 70

    Regards

    ReplyDelete
  4. Dear VP sir,

    Pls tell if we can still buy the sugar stocks which u recommended in 2012. They are now at much lower prices than they were in 2012.

    ReplyDelete
    Replies
    1. At that time govt had plans to completely de-control sugar price which not materialised .

      Delete
  5. Is it getting better for Adani Power?. It was one of your old recommendations. Can you please have a look at it in current circumstance. Q3 results also showed signs of turnaround.

    ReplyDelete
    Replies
    1. Huge debt is the major issue . Depends on your risk appetite .

      Delete
  6. Sir, when can we have a new rec. Thanks

    ReplyDelete
  7. Sir your views on
    Gujarat themis biosyn also
    The company has turned profitable
    Thank you

    ReplyDelete
  8. Sir

    Whats your view on Unitech, Prima & Rajoo Engineer??

    Thanks in advance

    ReplyDelete
  9. Sir, your silence to comments is saying lot of things.I know you are trying to find out another multibagger stock like la-opala,alphageo,avanti feeds,Granules,Arrow coated products,skm,Caplin etc.......hope so we get it soon. :)

    ReplyDelete
    Replies
    1. Due to some other engagements , forced to skip more messages in past few days .Sorry for that.

      Delete
  10. SIr

    Your views on PIX Transmissions?

    Thanks
    Biju

    ReplyDelete
  11. Dear VP sir,

    Your views on Krebs Biochemicals and Industries.

    http://www.vccircle.com/news/pharmaceuticals/2015/02/13/ipca-labs-picks-19-stake-krebs-biochem-hiking-it-30-makes-open-offer

    IPCA increased stake to 30% on Friday and company restarting operations in its units.

    Is fresh entry suggested at these levels for investor with high risk appetite?

    Thank you sir.

    ReplyDelete
    Replies
    1. Krebs is one stock I suggested earlier for risk takers in the following link:

      http://value-picks.blogspot.in/2010/11/diwali-wishes.html

      At that time company could not come back as expected . I hope , the same will happen now.

      Delete
    2. VP sir,

      Thanks a lot.

      This is zero revenue company trading at 65cr market cap. Can high risk takers take position even now?

      I agree their technology and specialization + FDA approval makes it high entry barrier, which is why Ranbaxy and IPCA shown interest in this company.

      Please reply sir. Thank you sir.

      Delete
    3. Yes . if a Zero revenue company for past many years trading at a market cap of Rs.65 Cr and a company like IPCA is now ready to subscribe shares @ Rs.54 and another major like Ranbaxy is holding more than 10 % stake , it is clear ,there should be something special in it .

      Delete
  12. Dear VP sir,
    Pls give ur view on NITIN FIRE PROTECTION Q3 Results.Is it a decent buy at current level?

    ReplyDelete
  13. your opinion on Aimco results..We are waiting for your reply

    ReplyDelete
    Replies
    1. Considering the seasonality of their business , result is not bad.

      Delete
  14. Sir, your observations on Bilcare Quarter Results please

    ReplyDelete
  15. Your views on bilcare. Results please

    ReplyDelete
  16. Sir, can you share your views on nagarjun oil refinary

    ReplyDelete
  17. Dear vp sir
    Sir can you share your veiw on kesar terminals and smkrg pistons

    ReplyDelete
    Replies
    1. Not tracking Kesar Terminal, Samkrg piston is an already suggested stock and no change in opinion

      Delete
  18. Dear Sirjee, anil sanghvi of sun pharma has signed definitive agreement to buy 23 %stake in Suzlon. I believe it is going to be hugely Positive for Suzlon. Any comment pls?

    ReplyDelete
    Replies
    1. If someone is willing to pump money in the form of equity in a debt ridden company,surely that is positive to a certain extent .

      Delete
  19. Hello Sir
    For Anyone and everyone who thinks that you have any insider connection, Suzlon update would have proved them wrong, Now looking at the current activities do you feel one can enter Suzlon now?

    ReplyDelete
    Replies
    1. Till now there is no clarity how this deal is going to structure. Whether this is an all cash deal or not is yet to known. Some reports saying ,Suzlon would take over solar panels firm PV Power Tech, which is controlled by Shanghvi's son Aalok via a stock deal. We can reach in conclusions once there is some more clarity in this deal.We must understand whether these deals are seperate or they are going to take stake by merging solar entity into suzlon and issuing shares in lieu of that .

      Delete
  20. sir what is the strategy in godavari drugs....i have entered around 80...i am sure of its long term prospectus and will hold onto it for long term...my question is related to fresh entry. is fresh entry and averaging out at low price is advisable at this stage? or should one wait till it consolidate?

    ReplyDelete
    Replies
    1. One firm holding more than 1 % stake is selling shares from Rs,26 level. Few more thousands left with them . I hope stock will rebound when the balance shares absorbed in market.

      Delete
  21. Sir
    What's your view on aurionPro Solutions Limited, is it a good time to accumulate it?
    Thanks

    ReplyDelete
  22. Sirji your views on venkys plz
    It result looks good

    ReplyDelete
  23. Sir please share your views on KOPRAN results.

    ReplyDelete
    Replies
    1. Result was below expectation, but not expecting much downside risk from here

      Delete
  24. Sir, Multibase india posted a good result..do u think at cmp.of 300+ its still an attractive bet for.long term?

    ReplyDelete
    Replies
    1. Business is steadily growing . An MNC affiliate with zero debt always deserving higher P/E . Further valuation depends on Govt decision on Air bags.

      Delete
  25. Hi sir,
    Request your analysis on dynemic products, recently the share price corrected from 100 to sub 50 levels, is it a value buy considering EPs 9.

    ReplyDelete
    Replies
    1. Not strictly tracking it. It seems Company profit also came down by more than half in Dec qtr

      Delete
  26. Dear sir, your view on lincoln pharma Q3 res
    ult please ,can we hold for long term.Regards thanking you

    ReplyDelete
  27. Sir, Will you review recommendation for booking loss in SUZLON? Or it is still avoid?

    ReplyDelete
  28. sirji, I bought panjab and sind bank at 61 rs. Now it is at 54 level. should i buy for average as sip?

    ReplyDelete
  29. sir your valuable views on ptc finance plz

    ReplyDelete
  30. Sirji, please advise on Praj Industries, should I buy it for long term.

    ReplyDelete

Followers

Tweet TopOfBlogs